Loading…
Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR-Mutant Lung Cancer Harboring De Novo MET Amplification
Saved in:
| Published in: | Journal of thoracic oncology 2016-07, Vol.11 (7), p.e83-e85 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c4455-20d459375eba84256d8b3f53f78674c8edb5caf4ba9c2c31d5073648d7c8cf813 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c4455-20d459375eba84256d8b3f53f78674c8edb5caf4ba9c2c31d5073648d7c8cf813 |
| container_end_page | e85 |
| container_issue | 7 |
| container_start_page | e83 |
| container_title | Journal of thoracic oncology |
| container_volume | 11 |
| creator | Gainor, Justin F. Niederst, Matthew J. Lennerz, Jochen K. Dagogo-Jack, Ibiayi Stevens, Sara Shaw, Alice T. Sequist, Lecia V. Engelman, Jeffrey A. |
| description | |
| doi_str_mv | 10.1016/j.jtho.2016.02.021 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1799563688</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S155608641600455X</els_id><sourcerecordid>1799563688</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4455-20d459375eba84256d8b3f53f78674c8edb5caf4ba9c2c31d5073648d7c8cf813</originalsourceid><addsrcrecordid>eNp9UcFu1DAQtRCIlsIPcEA-ciCL7diJI3FZpdsWaQuoKmfLsR3WS2JvbWdX8Bf94zrswhFpLI9n3ntjzQPgLUYLjHD1cbvYpo1fkJwvEMmBn4FzzFhV4JKj56cc8YqegVcxbhGiDFH-EpyRquGc1egcPF4GOcpkFbwzceddNDB52Pqxsy6XvYOrMPhkne2gdBq2wf4-Pa2DEn7LIOMSPNi0gUu9l04Z_QGurq_uitspydxaT-4HbOdGgDcydD7YXLg08Ivfe3i7uofLcTfY3qo_A1-DF70conlzui_A96vVfXtTrL9ef26X60JRylhBkKasKWtmOskpYZXmXdmzsq95VVPFje6Ykj3tZKOIKrFmqC4rynWtuOo5Li_A-6PuLviHycQkRhuVGQbpjJ-iwHXTsKqsOM9QcoSq4GMMphe7YEcZfgmMxGyF2IrZCjFbIRDJMeu_O-lP3Wj0P8rf3WcAPQIOfkgmxJ_DdDBBbIwc0kYgTGjJG1rMmqhGCBX5EJZpn440k5ezt5kRVbYgr90Go5LQ3v7vW0_seKqH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1799563688</pqid></control><display><type>article</type><title>Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR-Mutant Lung Cancer Harboring De Novo MET Amplification</title><source>Elsevier ScienceDirect Journals</source><creator>Gainor, Justin F. ; Niederst, Matthew J. ; Lennerz, Jochen K. ; Dagogo-Jack, Ibiayi ; Stevens, Sara ; Shaw, Alice T. ; Sequist, Lecia V. ; Engelman, Jeffrey A.</creator><creatorcontrib>Gainor, Justin F. ; Niederst, Matthew J. ; Lennerz, Jochen K. ; Dagogo-Jack, Ibiayi ; Stevens, Sara ; Shaw, Alice T. ; Sequist, Lecia V. ; Engelman, Jeffrey A.</creatorcontrib><identifier>ISSN: 1556-0864</identifier><identifier>EISSN: 1556-1380</identifier><identifier>DOI: 10.1016/j.jtho.2016.02.021</identifier><identifier>PMID: 26988570</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Erlotinib Hydrochloride - administration & dosage ; Female ; Gene Amplification ; Humans ; Lung Neoplasms - drug therapy ; Lung Neoplasms - genetics ; Lung Neoplasms - pathology ; Mutation ; Prognosis ; Proto-Oncogene Proteins c-met - genetics ; Pyrazoles - administration & dosage ; Pyridines - administration & dosage ; Receptor, Epidermal Growth Factor - genetics</subject><ispartof>Journal of thoracic oncology, 2016-07, Vol.11 (7), p.e83-e85</ispartof><rights>2016 International Association for the Study of Lung Cancer</rights><rights>Copyright © 2016 by the International Association for the Study of Lung Cancer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4455-20d459375eba84256d8b3f53f78674c8edb5caf4ba9c2c31d5073648d7c8cf813</citedby><cites>FETCH-LOGICAL-c4455-20d459375eba84256d8b3f53f78674c8edb5caf4ba9c2c31d5073648d7c8cf813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S155608641600455X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26988570$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gainor, Justin F.</creatorcontrib><creatorcontrib>Niederst, Matthew J.</creatorcontrib><creatorcontrib>Lennerz, Jochen K.</creatorcontrib><creatorcontrib>Dagogo-Jack, Ibiayi</creatorcontrib><creatorcontrib>Stevens, Sara</creatorcontrib><creatorcontrib>Shaw, Alice T.</creatorcontrib><creatorcontrib>Sequist, Lecia V.</creatorcontrib><creatorcontrib>Engelman, Jeffrey A.</creatorcontrib><title>Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR-Mutant Lung Cancer Harboring De Novo MET Amplification</title><title>Journal of thoracic oncology</title><addtitle>J Thorac Oncol</addtitle><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Erlotinib Hydrochloride - administration & dosage</subject><subject>Female</subject><subject>Gene Amplification</subject><subject>Humans</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - pathology</subject><subject>Mutation</subject><subject>Prognosis</subject><subject>Proto-Oncogene Proteins c-met - genetics</subject><subject>Pyrazoles - administration & dosage</subject><subject>Pyridines - administration & dosage</subject><subject>Receptor, Epidermal Growth Factor - genetics</subject><issn>1556-0864</issn><issn>1556-1380</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9UcFu1DAQtRCIlsIPcEA-ciCL7diJI3FZpdsWaQuoKmfLsR3WS2JvbWdX8Bf94zrswhFpLI9n3ntjzQPgLUYLjHD1cbvYpo1fkJwvEMmBn4FzzFhV4JKj56cc8YqegVcxbhGiDFH-EpyRquGc1egcPF4GOcpkFbwzceddNDB52Pqxsy6XvYOrMPhkne2gdBq2wf4-Pa2DEn7LIOMSPNi0gUu9l04Z_QGurq_uitspydxaT-4HbOdGgDcydD7YXLg08Ivfe3i7uofLcTfY3qo_A1-DF70conlzui_A96vVfXtTrL9ef26X60JRylhBkKasKWtmOskpYZXmXdmzsq95VVPFje6Ykj3tZKOIKrFmqC4rynWtuOo5Li_A-6PuLviHycQkRhuVGQbpjJ-iwHXTsKqsOM9QcoSq4GMMphe7YEcZfgmMxGyF2IrZCjFbIRDJMeu_O-lP3Wj0P8rf3WcAPQIOfkgmxJ_DdDBBbIwc0kYgTGjJG1rMmqhGCBX5EJZpn440k5ezt5kRVbYgr90Go5LQ3v7vW0_seKqH</recordid><startdate>201607</startdate><enddate>201607</enddate><creator>Gainor, Justin F.</creator><creator>Niederst, Matthew J.</creator><creator>Lennerz, Jochen K.</creator><creator>Dagogo-Jack, Ibiayi</creator><creator>Stevens, Sara</creator><creator>Shaw, Alice T.</creator><creator>Sequist, Lecia V.</creator><creator>Engelman, Jeffrey A.</creator><general>Elsevier Inc</general><general>Copyright by the International Association for the Study of Lung Cancer</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201607</creationdate><title>Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR-Mutant Lung Cancer Harboring De Novo MET Amplification</title><author>Gainor, Justin F. ; Niederst, Matthew J. ; Lennerz, Jochen K. ; Dagogo-Jack, Ibiayi ; Stevens, Sara ; Shaw, Alice T. ; Sequist, Lecia V. ; Engelman, Jeffrey A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4455-20d459375eba84256d8b3f53f78674c8edb5caf4ba9c2c31d5073648d7c8cf813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Erlotinib Hydrochloride - administration & dosage</topic><topic>Female</topic><topic>Gene Amplification</topic><topic>Humans</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - pathology</topic><topic>Mutation</topic><topic>Prognosis</topic><topic>Proto-Oncogene Proteins c-met - genetics</topic><topic>Pyrazoles - administration & dosage</topic><topic>Pyridines - administration & dosage</topic><topic>Receptor, Epidermal Growth Factor - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gainor, Justin F.</creatorcontrib><creatorcontrib>Niederst, Matthew J.</creatorcontrib><creatorcontrib>Lennerz, Jochen K.</creatorcontrib><creatorcontrib>Dagogo-Jack, Ibiayi</creatorcontrib><creatorcontrib>Stevens, Sara</creatorcontrib><creatorcontrib>Shaw, Alice T.</creatorcontrib><creatorcontrib>Sequist, Lecia V.</creatorcontrib><creatorcontrib>Engelman, Jeffrey A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of thoracic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gainor, Justin F.</au><au>Niederst, Matthew J.</au><au>Lennerz, Jochen K.</au><au>Dagogo-Jack, Ibiayi</au><au>Stevens, Sara</au><au>Shaw, Alice T.</au><au>Sequist, Lecia V.</au><au>Engelman, Jeffrey A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR-Mutant Lung Cancer Harboring De Novo MET Amplification</atitle><jtitle>Journal of thoracic oncology</jtitle><addtitle>J Thorac Oncol</addtitle><date>2016-07</date><risdate>2016</risdate><volume>11</volume><issue>7</issue><spage>e83</spage><epage>e85</epage><pages>e83-e85</pages><issn>1556-0864</issn><eissn>1556-1380</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26988570</pmid><doi>10.1016/j.jtho.2016.02.021</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1556-0864 |
| ispartof | Journal of thoracic oncology, 2016-07, Vol.11 (7), p.e83-e85 |
| issn | 1556-0864 1556-1380 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1799563688 |
| source | Elsevier ScienceDirect Journals |
| subjects | Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Erlotinib Hydrochloride - administration & dosage Female Gene Amplification Humans Lung Neoplasms - drug therapy Lung Neoplasms - genetics Lung Neoplasms - pathology Mutation Prognosis Proto-Oncogene Proteins c-met - genetics Pyrazoles - administration & dosage Pyridines - administration & dosage Receptor, Epidermal Growth Factor - genetics |
| title | Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR-Mutant Lung Cancer Harboring De Novo MET Amplification |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T12%3A43%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dramatic%20Response%20to%20Combination%20Erlotinib%20and%20Crizotinib%20in%20a%20Patient%20with%20Advanced,%20EGFR-Mutant%20Lung%20Cancer%20Harboring%20De%20Novo%20MET%20Amplification&rft.jtitle=Journal%20of%20thoracic%20oncology&rft.au=Gainor,%20Justin%20F.&rft.date=2016-07&rft.volume=11&rft.issue=7&rft.spage=e83&rft.epage=e85&rft.pages=e83-e85&rft.issn=1556-0864&rft.eissn=1556-1380&rft_id=info:doi/10.1016/j.jtho.2016.02.021&rft_dat=%3Cproquest_cross%3E1799563688%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4455-20d459375eba84256d8b3f53f78674c8edb5caf4ba9c2c31d5073648d7c8cf813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1799563688&rft_id=info:pmid/26988570&rfr_iscdi=true |